Umicore has collaborated with Microsoft to make use of artificial intelligence in order to accelerate its research in battery material technologies for electric vehicles. With this move, Umicore intends to create a customized AI environment that will analyze, synthesize and bring together vast and complex data from its proprietary battery materials research and development.

With the rise of megatrends in Europe such as electromobility and renewable energies which require silicones, Wacker Chemie has decided to build a new silicones production site in Czech Republic. Production at the site is expected to begin by the end of 2025.

GEA has commenced operations at a new fabrication, repair, logistics and training facility in Wisconsin, USA. The 20-million-dollar unit comprises of production capabilities to finalize separator, decanter as well as valve and pump assembly.

Lanxess has reshuffled the management positions of four business units. With this move, the company aims to provide fresh impetus for future growth in its consumer protection segment.

A consortium of 15 companies including Neste have successfully concluded a joint ‘E-Fuel research project’ in which high temperature electrolysis (SOEC), carbon capture, and hydrocarbon synthesis technologies were demonstrated and production of synthetic e-fuels was also accelerated.

Newcleo has collaborated with Maire’s subsidiaries Nextchem Tech and Tecnimont to study the application of Gen-IV nuclear technologies for the production of hydrogen and sustainable chemicals production.

Solenis has successfully acquired Cedarchem, a firm which specializes in water and wastewater treatment products for industrial and municipal markets in the USA. With this move, Solenis aims to offer its customers with improved chemical and wastewater treatment product and service offerings.

With an aim to increase its global elastomers production capacity, Arkema has started-up a new production unit in France. With the new unit, the firm is expected to increase its production capacity by 40 %.

BASF has invested a hefty double-digit million-euro amount to develop a new fermentation plant for biological and biotechnology-based crop protection products at its Ludwigshafen site in Germany.

Claimed to be Japan’s largest site for mammalian-based manufacturing capacity, the new facility will offer pre-clinical through commercial services for mammalian-based protein biologics, cell therapies, and messenger RNA.